×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| TRANSGENE BIOTEK LTD. | NA | NA | NA | NA | 32.2 | |
| Shree Ganesh Biotech (India) L | NA | NA | NA | NA | 31.1 | 66.2 |
| KK Shah Hospitals Limited | NA | NA | NA | NA | 30.3 |
Transgene Biotek Ltd., with Security Code 526139, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2021 | Mar 2022 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 0.1 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Expenses | 0.2 | 0.1 | 22.0 | 0.2 | 0.2 | 0.3 | 0.5 | 0.1 | 0.2 | 0.6 |
| Operating Profit | -0.2 | -0.1 | -12.0 | -0.1 | -0.1 | -0.3 | -0.4 | -0.1 | -0.1 | -0.5 |
| OPM % | 0% | -65.88% | -120.15% | -268.89% | -240% | -595.56% | -842.86% | -130.51% | -119.48% | -659.74% |
| Other Income | 0.0 | 0.1 | 4.4 | 0.0 | 0.0 | 0.1 | 0.7 | 0.0 | 0.0 | 0.0 |
| Interest | 0.1 | 0.1 | 3.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 |
| Depreciation | 2.5 | 2.5 | 2.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | -2.6 | -2.5 | -13.2 | -0.1 | -0.1 | -0.3 | 0.2 | -0.1 | -0.1 | -0.7 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -2.6 | -2.5 | -13.2 | -0.1 | -0.1 | -0.3 | 0.2 | -0.1 | -0.1 | -0.7 |
| EPS in Rs | -0.35 | -0.34 | -0.02 | -0.02 | -0.02 | -0.04 | 0.03 | -0.01 | -0.01 | 0 |
| Metrics | Dec 2021 | Mar 2022 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 0.1 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Expenses | 0.2 | 0.1 | 22.7 | 0.2 | 0.2 | 0.3 | 0.5 | 0.1 | 0.2 | 0.6 |
| Operating Profit | -0.2 | -0.1 | -12.7 | -0.1 | -0.1 | -0.3 | -0.4 | -0.1 | -0.1 | -0.5 |
| OPM % | 0% | -65.88% | -127.53% | -268.89% | -240% | -595.56% | -842.86% | -130.51% | -119.48% | -659.74% |
| Other Income | 0.0 | 0.1 | 4.4 | 0.0 | 0.0 | 0.1 | 0.7 | 0.0 | 0.0 | 0.0 |
| Interest | 0.1 | 0.1 | 3.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 |
| Depreciation | 2.5 | 2.5 | 2.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | -2.6 | -2.5 | -13.9 | -0.1 | -0.1 | -0.3 | 0.2 | -0.1 | -0.1 | -0.7 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -2.6 | -2.5 | -13.9 | -0.1 | -0.1 | -0.3 | 0.2 | -0.1 | -0.1 | -0.7 |
| EPS in Rs | -0.35 | -0.34 | -0.02 | 0 | -0.02 | -0.04 | 0.03 | -0.01 | -0.01 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 0% |
| 3 Years: | 42% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 25% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 5% |
| 3 Years: | 6% |
| 1 Year: | -31% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 0% |
| 3 Years: | 42% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 25% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 5% |
| 3 Years: | 6% |
| 1 Year: | -31% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|